Single-cell editing platform

Single-Cell Gene Editing Platform: One-Step Knockout Cloning for Ultimate Efficiency

Traditional cell line generation is a grueling process: polyclonal pool screening → positive monoclonal screening → monoclonal expansion. This typically takes 10-14 weeks and suffers from dominant clone bias, which compromises the representativeness of the final cell line.

EDITGENE has developed a disruptive Single-Cell Gene Editing Platform that deeply integrates single-cell dispensing, single-cell culturing, and gene editing. Utilizing the cutting-edge German Cytena UP.SIGHT system, single cells are precisely deposited into 96-well plates. Combined with our proprietary CFM cloning supplement (which drastically boosts cloning efficiency) and Flash-KO in-situ editing, researchers can obtain single-cell-derived edited lines in one step. This completely bypasses traditional polyclonal screening and shrinks the turnaround time to just 6-8 weeks.

Core Technical Advantages
UP.SIGHT
UP.SIGHT Single-Cell Dispensing
A premium 3D cell-printing system ensuring >99% dispensing accuracy to guarantee true monoclonality.
CFM
CFM Cloning Supplement
A proprietary formulation that promotes single-cell adhesion and proliferation, drastically elevating colony formation rates.
FLASH
FLASH Delivery Method
Performs gene editing directly at the single-cell level without waiting for expansion. Yields a 60-80% success rate for homozygous monoclonal knockouts.
Rapid Cycle
Rapid Cycle
Eliminates the polyclonal screening bottleneck, shortening timelines by 30% (down to 6-8 weeks).
Single-Cell Gene Editing vs. Conventional Workflows: Unmatched Leadership
Comparison Metric Conventional Limiting Dilution Electroporation / Viral Transfection + Selection
Monoclonal Isolation Method Manual limiting dilution; high randomness; prone to polyclonal contamination Limiting dilution after polyclonal pool screening; cumbersome steps
Multi-round Screening Yes (2-3 rounds) Yes (Antibiotic selection + Limiting dilution)
Turnaround Time 12-20 Weeks 14-18 Weeks
Cloning Efficiency 10-30% (Cell-line dependent) 10-30%
KO Success Rate (Monoclonal) 30-50% 40-60%
Cellular Damage Low (but requires frequent passaging) High (Electroporation and selection stress)
Automation Level Manual; high batch-to-batch variance Semi-automated
Applicable Cell Types Standard adherent cells Broad
Single-Cell Gene Editing Platform
UP.SIGHT precision plating; >99% single-cell accuracy
No: One-step monoclonal acquisition
8-10 Weeks (30% reduction)
31-62% (62.5% for 293T, 31.25% for HeLa)
60-100% (100% for HeLa, 80% for 293T)
Low (In situ transfection; no trypsinization required)
Fully Automated (UP.SIGHT image recognition & dispensing)
Broad (Covers both adherent and suspension cells)
Service Types

Single Gene KO (Standard)

8-10 Weeks
  • UP.SIGHT Plating + CFM Supplement + FLASH-RNP
  • KO in standard adherent/suspension cell lines
  • Homozygous monoclonal lines (≥2) + Sequencing report + Colony images

Multi-gene Co-knockout

10-12 Weeks
  • Simultaneous delivery of multiple sgRNAs + Single-cell screening
  • Double/Triple gene combined KO (e.g., immune checkpoint combinations)
  • Homozygous multi-KO monoclonal lines + Validation report

High-Throughput Arrayed KO

12-16 Weeks
  • 96-well pre-designed sgRNA library + Automated plating/transfection
  • Genome-wide screening, drug target discovery, pathway analysis
  • Monoclonal cell line per well (pool or clone options)

Point Mutation (Custom)

12-16 Weeks
  • Single-cell plating + FLASH-PE7 Prime Editing
  • SNVs, small indels (e.g., disease models)
  • Homozygous PM monoclonal lines + Sequencing report

Gene Knock-in (Custom)

12-16 Weeks
  • Single-cell plating + FLASH-KI (RNP+Donor) + NHEJ Inhibitor
  • Reporter KI, tag insertion, conditional alleles
  • Homozygous KI monoclonal lines + Sequencing/Flow report
Success Cases

293T B2M Knockout: Efficient Acquisition of 48 Homozygous Clones

Objective: Construct B2M knockout cell lines in 293T cells.

Workflow: UP.SIGHT single-cell plating → CFM-promoted cloning → FLASH-KO transfection.

Results: Achieving a 62.5% colony formation rate in 96-well plates and an 80% success rate for homozygous KO monoclones. The project cycle was shortened by 2-3 weeks.

A549 & HeLa B2M Knockout: 100% Knockout Success Rate

Objective: Construct B2M knockout cell lines in A549 and HeLa cells.

Workflow: UP.SIGHT single-cell plating → CFM-promoted cloning → FLASH-KO transfection.

Results: Formed 38 and 65 clones in 96-well plates respectively, with a 100% success rate for homozygous KO monoclones. High-quality cell lines were obtained in one step without additional screening.

HAP1 High-Throughput Knockout of 96 Different Genes

Objective: Simultaneously construct knockout lines for 96 distinct genes in HAP1 cells.

Workflow: 96-well single-cell plating → Target-specific FLASH-KO transfection per well.

Results: 70 clones were formed (72.9% efficiency), yielding 42 homozygous KO monoclones (60% success rate). This demonstrates the platform’s high reliability for high-throughput gene editing.

Contact Us

*
*
*
*
How did you hear about us:
Tag


Leave a Reply

Your email address will not be published.Required Fields are marked
Contact Us
*
*
*
*
How did you hear about us: